Trial Profile
An open label trial evaluating the pharmacokinetics and safety of an intravenously administered single dose of Feramyl 200 mg, 500 mg or 1500 mg vs. Ferinject 500 mg in patients suffering from anaemia following cardiac surgery
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Jan 2020
Price :
$35
*
At a glance
- Drugs Iron hydroxyethyl starch (Primary) ; Ferric carboxymaltose
- Indications Anaemia
- Focus Pharmacokinetics
- Sponsors Serumwerk Bernburg
- 26 Feb 2017 Status changed from recruiting to completed.
- 10 Nov 2015 New trial record